Association of IL-6 and IL-10 serum levels with genetic variants in diabetic neuropathy: Clinical findings from a Bangladeshi patient cohort
- 1Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
- 2Department of Medicine, Dhaka Medical College Hospital, Dhaka, Bangladesh.
Abstract
Background: Diabetic Neuropathy (DN) is a prevalent complication of diabetes linked to chronic inflammation. Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are key cytokines implicated in DN pathogenesis. This study investigates the association of IL6 and IL10 gene polymorphisms and serum levels with DN in the Bangladeshi population. Materials and methods: A case-control study was conducted with 225 participants: diabetic patients with DN (n = 75), diabetic patients without DN (n = 75), and healthy controls (n = 75). Genomic DNA was extracted for genotyping IL-6 (rs1800796) and IL-10 (rs1800896) SNPs via PCR. Serum cytokine levels were measured using ELISA. Results: Serum IL-6 levels were significantly higher in the DN group than in the other study groups (p < 0.0001), with the highest levels observed among individuals with the IL-6 rs1800796 CC genotype. In unadjusted analyses, the IL-6 CC genotype was associated with increased odds of DN compared with healthy controls (OR = 4.813, 95% CI: 1.752–13.85, p = 0.0040), as was the IL-10 GG genotype (OR = 2.679, 95% CI: 1.000–6.751, p = 0.0373). However, neither IL-6 nor IL-10 genotype remained independently associated with DN after multivariable adjustment. Serum IL-10 levels did not differ significantly among the study groups (p = 0.0948). Combined genotype analyses showed several nominal associations, although these findings were exploratory. Serum IL-6 showed promising discriminatory ability in distinguishing patients with DN from the other study groups, whereas IL-10 demonstrated limited discriminatory performance. Conclusion: These findings support further investigation of serum IL-6 as a potential candidate biomarker for diabetic neuropathy, whereas the independent contribution of the investigated IL-6 and IL-10 polymorphisms remains uncertain. Larger prospective studies with independent external validation are required before clinical application can be considered.
Related
- Extracellular vesicle-mediated restraint of hepatic CD74–NF-κB repairs diabetic neuropathy
- Characterization of diabetic peripheral neuropathy in a high-fat diet mouse model
- Association of MDM2 rs2279744 and rs937282 polymorphisms with breast cancer susceptibility and circulating MDM2 and p53 levels in Bangladeshi women: A case-control study
- Association of SDF-1β (rs1801157) and TCF7L2 (rs12255372) Gene Polymorphisms With Type 2 Diabetes Mellitus in the Bangladeshi Population: A Case-Control Study.
- Machine-assisted systematic review and meta-analysis of citrus flavonoids in streptozotocin-induced painful diabetic neuropathy
BibTeX
@article{das2026association,
title = {{Association of IL-6 and IL-10 serum levels with genetic variants in diabetic neuropathy: Clinical findings from a Bangladeshi patient cohort}},
author = {Rajib Das and Sheikh Zahir Raihan and Shyamjit Paul and Mohammad Shamsul Arefin Patwary and Abul Kalam Azad Chowdhury},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0360933},
url = {https://doi.org/10.1371/journal.pone.0360933},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association of IL-6 and IL-10 serum levels with genetic variants in diabetic neuropathy: Clinical findings from a Bangladeshi patient cohort
AU - Rajib Das
AU - Sheikh Zahir Raihan
AU - Shyamjit Paul
AU - Mohammad Shamsul Arefin Patwary
AU - Abul Kalam Azad Chowdhury
PY - 2026
DA - 2026/10/22
JO - PLOS One
DO - 10.1371/journal.pone.0360933
UR - https://doi.org/10.1371/journal.pone.0360933
AB - Background: Diabetic Neuropathy (DN) is a prevalent complication of diabetes linked to chronic inflammation. Interleukin-6 (IL-6) and Interleukin-10 (IL-10) are key cytokines implicated in DN pathogenesis. This study investigates the association of IL6 and IL10 gene polymorphisms and serum levels with DN in the Bangladeshi population. Materials and methods: A case-control study was conducted with 225 participants: diabetic patients with DN (n = 75), diabetic patients without DN (n = 75), and healthy controls (n = 75). Genomic DNA was extracted for genotyping IL-6 (rs1800796) and IL-10 (rs1800896) SNPs via PCR. Serum cytokine levels were measured using ELISA. Results: Serum IL-6 levels were significantly higher in the DN group than in the other study groups (p < 0.0001), with the highest levels observed among individuals with the IL-6 rs1800796 CC genotype. In unadjusted analyses, the IL-6 CC genotype was associated with increased odds of DN compared with healthy controls (OR = 4.813, 95% CI: 1.752–13.85, p = 0.0040), as was the IL-10 GG genotype (OR = 2.679, 95% CI: 1.000–6.751, p = 0.0373). However, neither IL-6 nor IL-10 genotype remained independently associated with DN after multivariable adjustment. Serum IL-10 levels did not differ significantly among the study groups (p = 0.0948). Combined genotype analyses showed several nominal associations, although these findings were exploratory. Serum IL-6 showed promising discriminatory ability in distinguishing patients with DN from the other study groups, whereas IL-10 demonstrated limited discriminatory performance. Conclusion: These findings support further investigation of serum IL-6 as a potential candidate biomarker for diabetic neuropathy, whereas the independent contribution of the investigated IL-6 and IL-10 polymorphisms remains uncertain. Larger prospective studies with independent external validation are required before clinical application can be considered.
SN - 1932-6203
ER -